SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023439
Filing Date
2023-07-05
Accepted
2023-07-05 16:15:16
Documents
12
Period of Report
2023-06-30
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37486
  Complete submission text file 0001493152-23-023439.txt   211785

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE eton-20230630.xsd EX-101.SCH 3021
3 XBRL LABEL FILE eton-20230630_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE eton-20230630_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3437
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 231069089
SIC: 2834 Pharmaceutical Preparations